We are live on
!
Find out more
HTC
Haverford Trust Company Portfolio holdings
AUM
$10.9B
1-Year Est. Return
18.64%
This Fund
S&P 500
This Quarter
Est. Return
+7.18%
1 Year Est. Return
+18.64%
3 Year Est. Return
+50.3%
5 Year Est. Return
+61.01%
10 Year Est. Return
+205.82%
AUM
$5.42B
AUM Growth
+$355M
(+7%)
Cap. Flow
+$24M
Cap. Flow
% of AUM
0.44%
Top 10 Holdings %
Top 10 Hldgs %
32.28%
Holding
309
New
18
Increased
89
Reduced
125
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$23M |
| 2 |
GAP
The Gap Inc
GAP
|
+$20.7M |
| 3 |
AB InBev
BUD
|
+$13.4M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$4.68M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$3.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$21.2M |
| 2 |
Kraft Heinz
KHC
|
+$19.7M |
| 3 |
Kimberly-Clark
KMB
|
+$11.4M |
| 4 |
Apple
AAPL
|
+$2.64M |
| 5 |
Amazon
AMZN
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.63% |
| 2 | Technology | 13.57% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 8.05% |
| 5 | Consumer Discretionary | 7.96% |
Similar funds
CA
BMSSC
GIM
SGA
CG
DCP
PF
BHCM
Haverford Trust Company's Q3 2018 Portfolio in Review
As of Q3 2018, Haverford Trust Company held 309 positions worth $5.42B, up 7% from $5.06B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Haverford Trust Company's Q3 2018 filing shows 18 new, 89 increased, 125 reduced and 10 closed positions. Its largest new stake was Sierra Wireless: 100,000 shares worth $2.01M. The largest sale was GSK, an estimated $21.2M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- Haverford Trust Company's largest Q3 2018 buy was Sierra Wireless: 100,000 shares worth $2.01M.
- Haverford Trust Company added most to Qualcomm in Q3 2018, an estimated $23M increase.
- Haverford Trust Company's biggest Q3 2018 reduction was GSK, cutting an estimated $21.2M.
- Haverford Trust Company fully exited ANI Pharmaceuticals in Q3 2018, selling an estimated $818K.
- Haverford Trust Company's ten largest holdings make up 32% of its $5.42B portfolio in Q3 2018.
- Haverford Trust Company opened 18 new positions and closed 10 in Q3 2018.
- Haverford Trust Company's portfolio value rose 7% quarter-over-quarter to $5.42B.
Based on Haverford Trust Company's 13F filing for Q3 2018, filed 8 Nov 2018.